Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting
Outcome of Board Meeting along with financial Results for the quarter ended 30th June, 202429-07-2024
29-07-2024
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for OUTCOME OF BOARD MEETING
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, July 29, 2024 has inter-alia, considered, adopted and approved following items of business: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the Quarter Ended 30th June, 2024 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co, Statutory Auditors of the Company; copies of which are attached hereunder; In furtherance to the intimation filed by the Company dated June 27, 2024; the trading window for trading in securities of the Company by insiders closed on July 01, 2024 till the end of 48 hours after the declaration of outcome of Board Meeting. The Board Meeting commenced at 04:00 p.m. and concluded at 07:15 p.m.29-07-2024
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Monday, 29Th July, 2024.
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to Reg 29 read with Regulation 33 of SEBI (LODR) Reg, 2015, that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Monday, 29th July, 2024 inter alia, to consider and approve the following: 1. To discuss, consider and approve Unaudited Financial Results of the Company for the Quarter ended June 30, 2024. 2. Any other matter with the permission of the Chair. Further, in continuation of our intimation dated June 27, 2024 and pursuant to Company''s 'Code of Conduct' formed under the SEBI (PIT' ) Regulations, 2015 and amendments thereunder, the trading window for dealing in the securities of the Company has been closed from July 01, 2024 and it shall remain closed until forty-eight hours after the date of declaration of results for the Quarter ended June 30, 2024. The same has been circulated to the Directors, Key Managerial Personnel, Employees of the Company and their immediate relatives.20-07-2024
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 201819-07-2024
Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Closure of Trading Window27-06-2024
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the F.Y. ended 31st March, 202430-05-2024
Fredun Pharmaceuticals Ltd - 539730 - Corporate Action-Board approves Dividend
Revision in Financial Results10-05-2024
Fredun Pharmaceuticals Ltd - 539730 - Revised Financial Results For The Financial Year 2023-24
Revised Financial Resuls10-05-2024
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Revised Outcome - Board Meetig Dated 07.05.2024
Revised outcome for the Board Meeting Dated 07.05.202410-05-2024